Goodwin advised Armira on the financing of its partnership with Osypka AG.
OSYPKA AG is an internationally recognized provider and partner for innovative medical technology, offering advanced products for interventional and pediatric cardiology and cardiac surgery, and providing global contract partners with technically and qualitatively sophisticated turnkey CDMO solutions, particularly in the field of electrically active implants and neurostimulation. Since its founding in 1977 by Prof. Dr. Peter Osypka, the company has stood for technical excellence and improving the quality of life and care of patients worldwide.
Armira is a Munich-based investment holding focused on direct equity investments in medium-sized, profitable family businesses as well as resilient growth companies in the DACH region, Northern Italy and beyond. Backed by an exclusive investor base of entrepreneurs and families, Armira offers capital and strategic support with a long-term perspective.
The deal team was led by Winfried M. Carli and Daniel Wagner and included Folko Moroni, Philipp Lauer and Rina Omura (all Munich), Rebecca Stöcklein and Felix Krüger (both Frankfurt) as well as Kevin Grumberg (New York) and Carlos Martinez (Los Angeles).